Ardea Biosciences, Inc. (RDEA) Reports Q1 Loss of $1.25/Share
Get Alerts RDEA Hot Sheet
Join SI Premium – FREE
Ardea Biosciences, Inc. (NASDAQ: RDEA) reported Q1 EPS of ($1.25), $0.27 worse than the analyst estimate of ($0.98). Revenue for the quarter came in at $1.5 million versus the consensus estimate of $3 million.
For earnings history and earnings-related data on Ardea Biosciences, Inc. (RDEA) click here.
For earnings history and earnings-related data on Ardea Biosciences, Inc. (RDEA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Intel slides in afterhours trading as Q1 revenue misses, Q2 outlook falls short
- Data I/o Corp (DAIO) Misses Q2 EPS by 7c
- Seacoast Banking Corporation of Florida (SBCF) Tops Q1 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!